Navigation Links
Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía
Date:9/2/2014

BARCELONA, España, September 2, 2014 /PRNewswire/ --

   - Los datos del registro global de fibrilación atrial muestran agentes antitrombóticos no utilizados óptimamente para prevenir la apoplejía    

-- Las presentaciones de GARFIELD-AF en el ESC CONGRESS 2014 ofrecen una perspectiva sobre el tratamiento y los resultados de pacientes en riesgo de sufrir apoplejía en la práctica clínica diaria --  

Los datos de casi 12.500 pacientes reclutados en el Global Anticoagulant Registry en la FIELD-Atrial Fibrillation (GARFIELD-AF), una iniciativa de investigación académica innovadora e independiente, han ilustrado que las estrategias de prevención de apoplejía para los pacientes que padecen fibrilación atrial (AF) permanecen sub-óptimos a pesar de la transición a una nueva era de anticoagulación, con terapias de anticoagulante oral antagonista  sin vitamina K (NOAC). Los hallazgos, presentados esta semana en el ESC Congress 2014, muestran que los patrones de tratamiento en la práctica clínica diaria no son consistentes con las directrices basadas en evidencia, y que el uso inapropiado y mal uso de terapia de anticoagulantes se asocia con los peores resultados para pacientes.  

GARFIELD-AF está dirigida por un comité directivo internacional bajo los auspicios del Thrombosis Research Institute (TRI), Londres, Reino Unido. Se trata de un estudio observacional diseñado para aclarar los tratamientos AF y resultados para pacientes, médicos y proveedores de sanidad. La mayoría de los datos existentes sobre la AF proceden de ensayos clínicos controlados, mientras que la carga sobre los pacientes y poblaciones en la práctica clínica diaria es menos conocida. Hasta un 2 % de la población tiene AF[1], un desorden común del ritmo cardi
'/>"/>

SOURCE GARFIELD-AF
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Adamas Pharmaceuticals presenta datos clínicos positivos para ADS-5102, un tratamiento para la disquinesia inducida por levodopa, en el Congreso Mundial del Parkinson
2. Enciclopedia online gratuita sobre el cáncer para la diagnosis y tratamiento del cáncer
3. Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke
4. One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines
5. EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023
6. Kalila Medical Announces CE Mark Approval For The Vado Steerable Sheath Used During Atrial Fibrillation Procedures
7. Daiichi Sankyo Submits Edoxaban Marketing Authorization Application to the EMA for Once-Daily Use for Stroke Prevention in Atrial Fibrillation and for the Treatment and Prevention of Recurrence of Venous Thromboembolism
8. Global Atrial Fibrillation Market Report 2013 - 2019
9. The Novel Oral Anticoagulants Will Continue to Drive Growth in the Atrial Fibrillation Drug Market
10. Daiichi Sankyos Once-Daily Edoxaban Meets Primary Efficacy Endpoint for Stroke Prevention and Superiority for the Principal Safety Endpoint Compared to Warfarin for Patients with Atrial Fibrillation in a Phase 3 Clinical Trial
11. Phase IIb Study of Vanoxerine Shows Strong Safety and Statistically Significant Efficacy Signals for Treatment of Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015  Delcath Systems, Inc. ... medical device company focused on oncology with an ... liver cancers, announces the reporting of data from ... Hydrochloride for Injection with the Delcath Hepatic Delivery ... presentation at the Society of Surgical Oncology (SSO) ...
(Date:3/26/2015)... 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" ... focus on Omega-3 therapies for cardiovascular disease and overall ... 763,752 common shares of the Corporation (the "Common Shares"). ... period of December 5 th , 2014 to March ... that is due on or before April 1, 2015. ...
(Date:3/26/2015)... 2015 Cardiologists at Beaumont Hospital, ... commercial implant of a device recently approved by the ... fibrillation. The Watchman Left Atrial Appendage Closure implant is ... to reduce the risk of stroke. Atrial ... more than 5 million Americans. Twenty percent of all ...
Breaking Medicine Technology:Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3
... , MOUNTAIN VIEW, Calif., Dec. 14 Alexza Pharmaceuticals, ... submitted its New Drug Application (NDA) for Staccato® loxapine (AZ-004) ... is an inhalation product candidate being developed for the rapid ... The IND for Staccato loxapine was filed ...
... , DENVER, Dec. 14 Corgenix Medical Corporation (OTC ... diagnostic test kits, and BG Medicine, Inc. (BGM), a ... agreement whereby Corgenix will manufacture BGM Galectin-3 diagnostic products ... BG Medicine. BG Medicine is seeking regulatory clearance in ...
Cached Medicine Technology:Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM) 2
(Date:3/27/2015)... March 27, 2015 Ticket Down is a ... CenturyLink Center in Omaha, Nebraska on Friday, May 8th ... more concert dates will be added in Omaha as Garth ... demand. , The Garth Brooks World Tour is continuing its ... announcement that Garth Brooks and Trisha Yearwood will bring their ...
(Date:3/27/2015)... March 27, 2015 DrugDev announced company ... Easy was named to the 2015 Philadelphia Business Journal ... list spotlights 40 dynamic, up-and-coming leaders less than 40 ... involvement. Winners are honored at an awards program in ... Philadelphia Business Journal. , Lyn Kremer, Publisher of the ...
(Date:3/27/2015)... Endure Yoga is launching WOD (Workout ... This new program matches yoga poses with functional fitness ... down. This program utilizes yoga to improve recovery, prevent ... , Karen Lefurgy, competitive athlete at CrossFit ... I started Crossfit® training, but quickly, due to time ...
(Date:3/27/2015)... According to Health Day , on March ... Syndrome (NAS) are causing alarm for Florida officials. Infants ... for a month of their lives- and can experience ... The condition is precipitated by drug use during pregnancy. ... employing medically assisted drug treatment) will also inflict NAS ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 SMI (Silicon ... announced it has launched the SM1120 MEMS based ultra-miniature ... The microsensor profile at only 220um x 75um ... to reach challenging locations. With industry leading in ... the SM1120 provides a broad operating pressure range from ...
Breaking Medicine News(10 mins):Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 2Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 3Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:Endure Yoga Introduces WOD Recovery Yoga 2Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:SMI Launches Catheter Mountable Pressure Sensor 2
... on the Judiciary Committee staff of Senator Tom Coburn, Mary ... as Of Counsel to assist in spearheading America,s ... confirmation of U.S. Supreme Court nominee Judge Sotomayor. , ... am very pleased to have Mary join our team. ...
... with poor prognosis. This warrants the development of ... have demonstrated poor efficacy of adenoviral gene therapy ... on pancreatic cancer cells such as the coxsackie ... seems a promising option to improve adenoviral entry ...
... 2009 While Ontario women live longer than men, ... and chronic conditions, according to a new women,s health ... What,s more, low-income women have more chronic conditions, greater ... high-income groups. While inequities in health among men ...
... donations exceed expectations , , BIRMINGHAM, England, June ... world of a crippling and potentially fatal disease, Rotary ... toward its US$200 Million Challenge, a fundraising effort to ... Chair Jonathan Majiyagbe announced the new figure to an ...
... ... New Depreciation Wizard Feature for its Asset Tracking Application, Passport Assets, Enabling its Customers to ... , ... 23, 2009 -- ASAP Systems today announced the release of a depreciation wizard ...
... , Incentive Programs Driving Activities and Behavior Changes to Reduce ... ( http://www.incentone.com ), the leading provider ... health care industry, announced today that ... millionth health milestone. The 2 million milestones driven by IncentOne,s ...
Cached Medicine News:Health News:Mary Harned Joins Americans United for Life, Set to Oppose Sotomayor Confirmation 2Health News:Adenoviral vector specifically targeted to EphA2 receptor in pancreatic cancer cells 2Health News:Ontario women live longer but don't prosper: Study 2Health News:Ontario women live longer but don't prosper: Study 3Health News:Ontario women live longer but don't prosper: Study 4Health News:Rotary Marks Progress in Drive to Eradicate Polio 2Health News:Rotary Marks Progress in Drive to Eradicate Polio 3Health News:ASAP Systems Launches New Depreciation Feature Enabling its Customers to Develop Custom Formulas to Calculate Depreciation Of Their Fixed Assets Inventory 2Health News:IncentOne Achieves 2 Millionth Health Milestone 2
This design features a solid red iris....
This pattern transform your pupils into narrow slits surrounded by eye stopping yellow. Works well with kitty-cat costumes....
This camouflaging lens features the solid black stripes of the lightning fast African zebra, on a white iris background....
Silicone tip cannula angled at 7 mm, sterile, disposable (bx/10)....
Medicine Products: